European Medicines Agency excellence in pharmacovigilance: Clinical trials and post-marketing
Event
Corporate
Clinical trials
Medicines
Date
- Monday, 1 October 2012, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
This training course has been developed in accordance with the requirements as set out in the new pharmacovigilance legislation and guidelines on good pharmacovigilance practices (GVP). It addresses key topics such as definitions and methods in pharmacovigilance, regulatory aspects in pharmacovigilance including practical examples, diagnosis and management of adverse drug reactions, signal detection and risk management. Places limited.